earningsVivos TherapeuticsFri, Aug 14, 2026, 9:52 PMPositive

Vivos Therapeutics Posts Strong Q2 2026 Revenue Growth

Vivos Therapeutics has reported strong revenue growth for the second quarter of 2026, highlighting its financial performance and operational updates during the earnings call. The company continues to demonstrate robust growth in its sector.

Product intelligence

Explore the WPN directory

Discover products, startups, and technologies across AI, media, finance, software, and more.

Explore products